These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3185294)

  • 21. Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes.
    Carretti N; Florio P; Reis FM; Comai S; Bertazzo A; Petraglia F
    Climacteric; 2010 Apr; 13(2):141-6. PubMed ID: 20082603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new therapeutic approach to menopausal sudden flushes and psychofunctional disorders (author's transl)].
    Quereux C; Ezes H; Deltour G; Decaux J; Dorangeon P; Wahl P
    Sem Hop; 1980 Oct; 56(37-38):1453-9. PubMed ID: 6254160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of veralipride in menopausal sudden flushes (author's transl)].
    Wesel S; L'Hermite M
    Sem Hop; 1980 Oct; 56(37-38):1465-7. PubMed ID: 6254162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Agreal: its acceptibility. Review of the literature].
    Brient-Clabaux J
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):167-70. PubMed ID: 3922036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A clinical trial of veralipride in menopausal complaints (author's transl)].
    Lefevre J
    Sem Hop; 1982 Feb; 58(7):411-3. PubMed ID: 6280313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The treatment of hot flashes due to menopause. Comparative study of two drugs (author's transl)].
    Renaud R; Macler J
    Sem Hop; 1981 Feb 18-25; 57(7-8):353-5. PubMed ID: 6261369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes.
    Wesel S; Bourguignon RP; Bosuma WB
    Curr Med Res Opin; 1984; 8(10):696-700. PubMed ID: 6327190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of different dopamine agonists and antagonists on post-menopausal hot flushes.
    Zichella L; Falaschi P; Fioretti P; Melis GB; Cagnacci A; Gambacciani M; Mancini S
    Maturitas; 1986 Oct; 8(3):229-37. PubMed ID: 3784919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A multicenter comparison of veralipride versus placebo in the vasomotor flushes of menopause. An evaluation of the prolonged effect].
    Boulot P; Viala JL
    Rev Fr Gynecol Obstet; 1988 Dec; 83(12):823-7. PubMed ID: 3064254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
    Robyn C; Vekemans M
    Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study.
    Vercellini P; Sacerdote P; Trespidi L; Manfredi B; Panerai AE; Crosignani PG
    Fertil Steril; 1994 Nov; 62(5):938-42. PubMed ID: 7926138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of menopausal hot flushes with a nonhormonal medication, veralipride].
    Marzolf G; Eberst B; Aerts A; Lecornu C; Mark J; Gandar R
    Sem Hop; 1982 Nov; 58(41):2382-4. PubMed ID: 6297023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of early menopause. A report of 2 cases].
    Gicquel A
    Sem Hop; 1983 Jan; 59(1):47-8. PubMed ID: 6297087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Worsening of Parkinsonism after the use of veralipride for treatment of menopause: case report.
    Teive HA; Sa DS
    Arq Neuropsiquiatr; 2001 Mar; 59(1):123-4. PubMed ID: 11299446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].
    Masmoudi K; Decocq G; Chetaille E; Rosa A; Mizon JP; Andréjak M
    Therapie; 1995; 50(5):451-4. PubMed ID: 8571284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Respiratory dyskinesia induced by veralipride].
    Marta-Moreno E; Gracia-Naya M; Marzo-Sola ME
    Rev Neurol; 1997 Feb; 25(138):245-7. PubMed ID: 9147748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of an novel molecule, veralipride, in the treatment of menopausal disorders].
    Grall JY
    Sem Hop; 1982 Nov; 58(43):2535-7. PubMed ID: 6297046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intractable menopausal disorders cured by veralipride (author's transl)].
    Angeli S; Fougère P
    Sem Hop; 1982 Jan; 58(2):111-2. PubMed ID: 6276994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Panic-like symptoms after veralipride withdrawal.
    Iruela LM; Caballero L; Ibánez-Rojo V; Palanca I
    J Clin Psychiatry; 1993 Dec; 54(12):488-9. PubMed ID: 8276741
    [No Abstract]   [Full Text] [Related]  

  • 40. Veralipride-induced acute coronary syndrome unmasking a non-secreting pheochromocytoma.
    Montemurro D; Rossi GP
    J Endocrinol Invest; 2006; 29(7):650-2. PubMed ID: 16957415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.